Lung Cancer Detection Articles & Analysis
16 news found
We are delighted and extremely grateful to have this financial support to expand our global R&D collaboration with leading institutions that are evaluating BioMark’s early lung cancer detection assay as we are rapidly proceeding into commercialization phase in North ...
(“BioMark” or the “Company”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce several updates from ongoing clinical trial using the Company’s liquid biopsy test for early cancer detection and ...
Abstract title: “Metabolomic Profiling for the Early Detection of Lung Cancer”. The results demonstrated the high accuracy of BioMark’s quantitative metabolomic platform to identify early-stage lung cancer in retrospective plasma samples from individual with smoking history compared to ...
It is a special time to gather with loved ones and check-in to make sure everyone is happy and healthy. November is also lung cancer awareness month. VisionGate wants to help you, your family and loved ones learn more about who is at risk, the impact, and the types of lung cancer. Because keeping yourself informed about the ...
Other companies have developed their own technologies, many of which are aimed at detecting and providing volumetric measurements of pulmonary nodules. “Pulmonary nodules are a big topic, particularly with the advent of chest CT in high-risk patients for the early detection of lung cancer,” Krestin states. There are ...
ByFluidda
(“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today that it’s abstract titled “Metabolomic Profiling for the Early Detection of Lung Cancer” has been accepted for ...
(Nasdaq: GH), a leading precision oncology company, announced today the enrollment of the first patient in the SHIELD (Screening for HIgh-frEquency maLignant Disease) LUNG study, a nearly 10,000-patient prospective, registrational study to evaluate the performance of its next-generation Guardant SHIELD blood test in detecting lung ...
New study data presented at the European Congress of Cytology – held from 3-6 Oct in Warsaw, Poland – confirmed that X-ZELL is able to detect tumour-associated circulating atypical cells in the blood of lung cancer patients The dataset comprised interim results from a pilot study carried out in Thailand by X-ZELL and Dr Kittipong ...
Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, has secured $55 million from a syndicate of leading life science investors in an oversubscribed financing round. ...
August 1 marks World Lung Cancer Day -- a time to raise awareness of the need for increased lung cancer research and innovation. Anyone can get lung cancer. Here are the facts you need to know: Lung cancer is the leading cause of cancer ...
These findings promote new disease interception capability for the detection of early stage lung cancer and assessment of personalized immunotherapy efficacy in lung cancer. Previous research has demonstrated that the LuCED lung test, a non-invasive liquid biopsy sputum assay, has potential to ...
This study was done using patient sputum from normal and lung cancer patients. Further work will develop the MAC detection feature set and emphasize results at the case rather than cellular level. ...
VisionGate is a clinical stage oncology pharmaceutical and diagnostics company focused on the early detection and prevention of cancer. Our lead investigative pharmaceutical drug is oral iloprost, currently in clinical development for the treatment of pre-cancerous bronchial dysplasia and the prevention of lung ...
Cancer Diagnostics Services: Our initial cancer diagnostic services test, the LuCED® lung test, has been developed to support the early detection of lung cancer. ...
In addition, Porsche will bring several special cars from the Porsche Museum in Stuttgart. About Lung Cancer Lung Cancer kills more people each year than the other major cancers combined (approx 160,000 people per year in the U.S. alone). ...
For more than three years, the Bonnie J. Addario Lung Cancer Foundation in San Francisco and the Joan Gaeta Lung Cancer Fund (formerly Foundation) in Atlanta, have worked tirelessly back and forth across the country in their efforts to eradicate lung cancer. ...